“Digital Clinicians” Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial
JMIR Diabetes · 30.07.2025 · 10 · e63503-e63503
DOI: 10.2196/63503 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Diabetes, online erschienen am 30.07.2025. Verfasst von Sean Coleman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diabetes, Endocrinology, and Metabolism, University Hospital Galway, Newcastle Rd, Galway, H91 YR71, Ireland, 353 851604880. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Artificial intelligence (AI) chatbots have shown competency in a range of areas, including clinical note taking, diagnosis, research, and emotional support. An obesity epidemic, alongside a growth in novel injectable pharmacological solutions, has put a strain on limited resources.
Objective
This study aimed to investigate the use of a chatbot integrated with a digital avatar to create a “digital clinician.” This was used to provide mandatory patient education for those beginning semaglutide once-weekly self-administered injections for the treatment of overweight and obesity at a national center.
Methods
A “digital clinician” with facial and vocal recognition technology was generated with a bespoke 10- to 15-minute clinician-validated tutorial. A feasibility randomized controlled noninferiority trial compared knowledge test scores, self-efficacy, consultation satisfaction, and trust levels between those using the AI-powered clinician avatar onsite and those receiving conventional semaglutide education from nursing staff. Attitudes were recorded immediately after the intervention and again at 2 weeks after the education session.
Results
A total of 43 participants were recruited, 27 to the intervention group and 16 to the control group. Patients in the “digital clinician” group were significantly more knowledgeable postconsultation (median 10, IQR 10‐11 vs median 8, IQR 7‐9.3; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diabetes, Endocrinology, and Metabolism, University Hospital Galway, Newcastle Rd, Galway, H91 YR71, Ireland, 353 851604880.
- School of Medicine, University of Galway, Galway, Ireland.
- School of Psychology, University of Auckland, Auckland, New Zealand.
- School of Mathematics and Statistical Science, University of Galway, Galway, Ireland.
- School of Psychology, University of Galway, Galway, Ireland.
Zitieren
APA
Coleman, S., Lynch, C., Worlikar, H., Kelly, E., Loveys, K., Simpkin, A. J., Walsh, J. C., Broadbent, E., Finucane, F. M., & O' Keeffe, D. (2025). “Digital Clinicians” Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial. JMIR Diabetes, 10, e63503-e63503. https://doi.org/10.2196/63503
Vancouver
Coleman S, Lynch C, Worlikar H, Kelly E, Loveys K, Simpkin AJ, et al. “Digital Clinicians” Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial. JMIR Diabetes. 2025;10:e63503-e63503. doi:10.2196/63503
BibTeX
@article{Coleman2025,
author = {Coleman, Sean and Lynch, Caitríona and Worlikar, Hemendra and Kelly, Emily and Loveys, Kate and Simpkin, Andrew J and Walsh, Jane C and Broadbent, Elizabeth and Finucane, Francis M and O' Keeffe, Derek},
title = {“Digital Clinicians” Performing Obesity Medication Self-Injection Education: Feasibility Randomized Controlled Trial},
journal = {JMIR Diabetes},
year = {2025},
volume = {10},
pages = {e63503--e63503},
doi = {10.2196/63503}
}
EUVIMED